CSL’s $760m bet on bleeding disorder biotech becomes public knowledge
SYDNEY: CSL will invest up to $760 million in Dutch biotech VarmX, marking the healthcare
SYDNEY: CSL will invest up to $760 million in Dutch biotech VarmX, marking the healthcare
FEATURED
Multigenerational affordable housing plan for near city suburb
Most important race of my life is finding a cure for dementia
Best affordable seniors housing design for Global Awards shortlisted
City now ready to expropriate 400 buildings to build social housing
Best retirement housing design for Global Awards shortlisted
Six-storey social housing development now on drawing board
INNOVATION
